Device Trial Radar · NCT02649946
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Last checked: Nov 20, 2026Latest source record: Dec 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
Jun 2016
Primary completion
Aug 2018
Study completion Feb 2021
Sponsor
- Lead sponsor
- C. R. BardPublic (BDX)
- Sponsor type
- Industry
- First posted
- Jan 8, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
Conditions
- Stenosis
- Restenosis
Interventions
Covera Vascular Covered Stent following PTADevice
Treatment of stenoses with primary percutaneous transluminal angioplasty (PTA) and placement of the Covera Vascular Covered Stent.
Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA BalloonProcedure
Treatment of stenoses with PTA only
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness Endpoint: Number of Participants With Target Lesion Primary Patency (TLPP)Time frame: 6 months post index procedure
- Number of Participants With Freedom From AV Access Circuit Localized or Systemic Serious Adverse EventsTime frame: 30 days post index procedure
Locations
24 sites in 8 countries. Site status is shown where the registry gives one.
Southwest Vascular Center
Tempe, Arizona
Alliance Research Centers
Laguna Hills, California
Radiology Imaging Associates
Englewood, Colorado
21 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.